Skip to main content
. 2014 Sep 30;6(4):2035–2048. doi: 10.3390/cancers6042035

Table 1.

Schedule of IL-2 treatment repeated for 4 consecutive weeks with a 4-week rest period until progression of the disease or intolerable toxicity.

Day of Week 1 2 3 4 5 6 7
IL-2 bid x x
IL-2/die x x x

IL-2 bid: subcutaneous Interleukin-2 one million IU/m2 twice a day. IL-2/die: subcutaneous Interleukin-2 one million IU/m2 once a day.